Niagen Bioscience (NAGE) Capital Leases (2011 - 2024)

Niagen Bioscience (NAGE) reported Capital Leases of $2000.0 for Q3 2024, down 85.71% year-over-year from $14000.0 in Q4 2023, and down 66.67% quarter-over-quarter from $6000.0 in Q2 2024.

Niagen Bioscience (NAGE) Capital Leases (2011 - 2024) Analysis & Trends

Niagen Bioscience (NAGE) has 12 years of Capital Leases data on file, last reported at $2000.0 in Q3 2024.

  • Capital Leases for Q3 2024 came in at $2000.0, down 85.71% year-over-year; the trailing twelve-month figure through Sep 2024 was $2000.0 (down 85.71% YoY), and the FY2023 annual result was $12000.0, down 45.45% from the prior year.
  • Capital Leases slipped to $2000.0 in Q3 2024 per NAGE's latest filing, from $6000.0 in the prior quarter.
  • Over five years, Capital Leases peaked at $36000.0 in Q1 2020 and troughed at $2000.0 in Q3 2024.
  • A 5-year average of $16076.9 and a median of $14000.0 in 2023 frame the typical range for Capital Leases.
  • The sharpest annual moves came in 2020 and 2024: Capital Leases climbed 11.11% in 2020, then plunged 85.71% in 2024.
  • A 5-year view of Capital Leases shows it stood at $20000.0 in 2020, then sank by 45.0% to $11000.0 in 2021, then jumped by 100.0% to $22000.0 in 2022, then plunged by 45.45% to $12000.0 in 2023, then tumbled by 83.33% to $2000.0 in 2024.
  • Business Quant data shows NAGE's Capital Leases at $2000.0 in Q3 2024, $6000.0 in Q2 2024, and $9000.0 in Q1 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn -
2 Belite Bio 56,560.00 Bn 56,560.00 Bn -
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn -
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn -
6 Evaxion A 1,536.68 Bn 1,536.67 Bn -
7 Psyence Biomedical 238.34 Bn 238.33 Bn -
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn
9 Abivax 95.45 Bn 95.45 Bn -
10 Niagen Bioscience 280.11 Mn 213.56 Mn 19.98 Mn

Historic Data

Download Data
DateValue
Sep 30, 2024 2,000.00
Jun 30, 2024 6,000.00
Mar 31, 2024 9,000.00
Dec 31, 2023 12,000.00
Sep 30, 2023 14,000.00
Jun 30, 2023 17,000.00
Mar 31, 2023 20,000.00
Dec 31, 2022 22,000.00
Sep 30, 2021 11,000.00
Jun 30, 2021 13,000.00
Dec 31, 2020 20,000.00
Jun 30, 2020 27,000.00
Mar 31, 2020 36,000.00
Dec 31, 2019 18,000.00
Sep 30, 2019 70,000.00
Jun 30, 2019 121,000.00
Mar 31, 2019 94,000.00
Dec 31, 2018 137,000.00
Sep 30, 2018 178,000.00
Jun 30, 2018 219,000.00